Singapore markets close in 5 hours 33 minutes

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.8700+0.2600 (+5.64%)
At close: 04:00PM EDT
4.7800 -0.09 (-1.85%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 481.64M
Enterprise value 367.62M
Trailing P/E 11.63
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)25.96
Price/book (mrq)2.96
Enterprise value/revenue 22.11
Enterprise value/EBITDA -0.76

Trading information

Stock price history

Beta (5Y monthly) 1.30
52-week change 3121.36%
S&P500 52-week change 324.52%
52-week high 35.1400
52-week low 31.9000
50-day moving average 33.0132
200-day moving average 33.2657

Share statistics

Avg vol (3-month) 3851.83k
Avg vol (10-day) 3514.52k
Shares outstanding 598.9M
Implied shares outstanding 6103.18M
Float 841.92M
% held by insiders 141.87%
% held by institutions 129.55%
Shares short (15 May 2024) 41.61M
Short ratio (15 May 2024) 40.91
Short % of float (15 May 2024) 43.05%
Short % of shares outstanding (15 May 2024) 41.63%
Shares short (prior month 15 Apr 2024) 4509.36k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-379.17%

Management effectiveness

Return on assets (ttm)-20.85%
Return on equity (ttm)-36.68%

Income statement

Revenue (ttm)14.8M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -54.5M
Net income avi to common (ttm)-54.58M
Diluted EPS (ttm)-0.6900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)104.82M
Total cash per share (mrq)1.05
Total debt (mrq)3.33M
Total debt/equity (mrq)2.30%
Current ratio (mrq)7.78
Book value per share (mrq)1.46

Cash flow statement

Operating cash flow (ttm)-42.58M
Levered free cash flow (ttm)-24.21M